Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, was corresponding author on a study published online in the New England Journal of Medicine which shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation. Multiple media outlets covered the study and findings, including medWire News, MedicalResearch.com and Healio Pulmonology, among others. Dr. Criner presented the research findings at the American Thoracic Society International Conference.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH